Category: From Newswise – Addiction

Argonne and UChicago researchers used high-resolution technologies to see how dopamine circuitry in mice is affected by addictive drugs. The results answered older structural questions, while raising new ones about plasticity and recovery in the brain.

Living in an Oxford House recovery home can protect at-risk populations from COVID-19, according to new research from DePaul University.

People in the U.S. had a billion more drinks per month from February 2020 to November 2020. A Penn State Heath addiction expert discusses when it’s time to quit alcohol.

For some, attending holiday events with alcohol present, being around the people with whom they used to drink or the smell of their favorite drink can be hard to resist, especially for those with alcohol use disorder.

Smartphone apps to track blood alcohol abound, but until now had little evidence to show they help manage drinking in young adults. A new University of Florida study shows that heavy drinkers age 21-25 who weren’t trying to cut back on alcohol reduced their drinking by four and a half drinks per week while using the apps — nearly one drink less on each day they imbibed.

Survey study finds links to sense of control, FOMO, and repetitive negative thinking.

The University of Texas at El Paso will develop a sustainable public health intervention to suppress human immunodeficiency virus (HIV) in people who use drugs in the El Paso-Ciudad Juarez border region. The initiative will be funded by a $3 million grant from the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA).

An international study led by UBC Okanagan researchers suggests repeated use of small doses of psychedelics such as psilocybin or LSD can be a valuable tool for those struggling with anxiety and depression.

The Bronx is home to more than 27,000 people living with HIV, the majority of whom are Black or Hispanic men. People living with HIV have an increased risk for depression and substance use, which in turn can make adhering to daily antiviral treatments difficult, negatively impacting both quality of life and overall health.

Now, the National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine and Montefiore Health System two five-year grants totaling $7.6 million to study the structural and chemical changes in the brain of people living with HIV, depression, and cannabis use disorder.